Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Published 26/02/2024, 12:03
Updated 26/02/2024, 13:10
© Reuters. Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

Shares of Li Auto Inc. (NASDAQ: LI) rose sharply in today’s pre-market trading after the company reported fourth-quarter financial results above estimates and issued first-quarter guidance.

Li Auto posted adjusted earnings of 30 cents per share, beating market estimates of 29 cents per share. The company’s quarterly sales came in at $5.88 billion versus expectations of $5.48 billion.

Li Auto shares surged 8% to $37.56 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

  • ImmunityBio, Inc. (NASDAQ: IBRX) shares climbed 12.3% to $3.93 in pre-market trading after dipping 33% on Friday.
  • Bowlero Corp. (NYSE: BOWL) shares gained 6.5% to $13.05 in pre-market trading.
  • Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares gained 5.3% to $13.57 in pre-market trading. Alvotech and Teva announced the U.S. approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira.
  • Amer Sports, Inc. (NYSE: AS) shares gained 5.2% to $16.34 in pre-market trading after adding over 3% on Friday.
  • SES AI Corporation (NYSE: SES) shares climbed 5.1% to $1.45 in pre-market trading. SES AI is expected to release its 2023 fourth quarter business results after the closing bell on Feb. 26, 2024.
  • Berkshire Hathaway Inc. (NYSE: BRK-B) shares rose 5% to $438.08 in pre-market trading. Warren Buffett Said Berkshire is expected to maintain its investment in Occidental Petroleum indefinitely.
  • BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares rose 4.9% to $5.99 in pre-market trading. BioCryst Pharmaceuticals is projected to report its fourth quarter 2023 financial results on Feb. 26, 2024.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Investor Sentiment Edges Lower, But Fear & Greed Index Remains In 'Extreme Greed' Zone

Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.